jaypirca

Generic: pirtobrutinib

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name jaypirca
Generic Name pirtobrutinib
Labeler eli lilly and company
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

pirtobrutinib 50 mg/1

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-6902
Product ID 0002-6902_d1386cab-a58a-496f-af23-470b59b7831e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA216059
Listing Expiration 2026-12-31
Marketing Start 2023-01-27

Pharmacologic Class

Established (EPC)
kinase inhibitor [epc]
Mechanism of Action
bruton's tyrosine kinase inhibitors [moa] p-glycoprotein inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2c19 inhibitors [moa] cytochrome p450 3a inhibitors [moa] breast cancer resistance protein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00026902
Hyphenated Format 0002-6902

Supplemental Identifiers

RxCUI
2629343 2629349 2629351 2629353
UNII
JNA39I7ZVB
NUI
N0000175605 N0000193934 N0000185503 N0000187062 N0000182140 N0000190114 N0000190113

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name jaypirca (source: ndc)
Generic Name pirtobrutinib (source: ndc)
Application Number NDA216059 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 30 TABLET, COATED in 1 BOTTLE (0002-6902-30)
source: ndc

Packages (1)

0002-6902-30 30 TABLET, COATED in 1 BOTTLE (0002-6902-30)

Ingredients (1)

pirtobrutinib (50 mg/1)

Linked Drug Pages (1)

JAYPIRCA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d1386cab-a58a-496f-af23-470b59b7831e", "openfda": {"nui": ["N0000175605", "N0000193934", "N0000185503", "N0000187062", "N0000182140", "N0000190114", "N0000190113"], "unii": ["JNA39I7ZVB"], "rxcui": ["2629343", "2629349", "2629351", "2629353"], "spl_set_id": ["bd551845-0878-49a4-860f-839b83f6b801"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Bruton's Tyrosine Kinase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (0002-6902-30)", "package_ndc": "0002-6902-30", "marketing_start_date": "20230127"}], "brand_name": "JAYPIRCA", "product_id": "0002-6902_d1386cab-a58a-496f-af23-470b59b7831e", "dosage_form": "TABLET, COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Bruton's Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0002-6902", "generic_name": "pirtobrutinib", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "JAYPIRCA", "active_ingredients": [{"name": "PIRTOBRUTINIB", "strength": "50 mg/1"}], "application_number": "NDA216059", "marketing_category": "NDA", "marketing_start_date": "20230127", "listing_expiration_date": "20261231"}